Assessment of the safety and probiotic characteristics of Lactobacillus salivarius CGMCC20700 based on whole-genome sequencing and phenotypic analysis

Abstract

Lactic acid bacteria are generally regarded as alternatives to antibiotics in livestock and poultry farming, especially Lactobacillus strains, which are safe and have probiotic potential. Although Lactobacillus salivarius has long been proposed to be a probiotic, the understanding of the roles of this species is still in its infancy. Here, a strain of L. salivarius CGMCC20700 isolated from the intestinal mucosa of Yunnan black-bone chicken broilers was investigated in the context of its safety and probiotic characteristics by whole-genome sequencing in parallel with phenotypic analysis. Whole-genome sequencing results showed that L. salivarius CGMCC20700 has a single scaffold of 1,737,577 bp with an average guanine-to-cytosine (GC) ratio of 33.51% and 1,757 protein-coding genes. The annotation of Clusters of Orthologous Groups (COG) classified the predicted proteins from the assembled genome as possessing cellular, metabolic, and information-related functions. Sequences related to risk assessment, such as antibiotic resistance and virulence genes, were identified, and the strain was further confirmed as safe according to the results of antibiotic resistance, hemolytic, and acute oral toxicology tests. Two gene clusters of antibacterial compounds and broad-spectrum antimicrobial activity were identified using genome mining tools and antibacterial spectrum tests. Stress resistance genes, active stressor removal genes, and adhesion related genes that were identified and examined with various phenotypic assays (such as stress tolerance tests in acids and bile salts and auto aggregation and hydrophobicity assays). The strain showed a high survival rate in the presence of bile salts and under acidic conditions and exhibited significant auto aggregation capacity and hydrophobicity. Overall, L. salivarius CGMCC20700 demonstrated excellent safety and probiotic potential at both the genomic and physiological levels and can be considered an appropriate candidate probiotic for livestock and poultry farming.

In Silico Safety Assessment of Bacillus Isolated from Polish Bee Pollen and Bee Bread as Novel Probiotic Candidates

“…Interestingly, methionine sulfoxide reductase genes ( msrA and msrB ) that can repair oxidized methionine residues by ROS in proteins were detected [ 99 , 100 ]. Moreover, the genes ( dlt A–D) coding for immunomodulatory activities and some additional general stress genes were also identified [ 101 ]. These findings suggest that strains may withstand multiple stress conditions and are consistent with the adaptability characteristics of the gastrointestinal tract.…”

Probiotic Insights from the Genomic Exploration of Lacticaseibacillus paracasei Strains Isolated from Fermented Palm Sap

“…The six isolates harbored an effective oxidative stress response system ( Table 2 ) that supported survival and damage repair under aerobic conditions during production. The correlation between genetic determinants and phenotypic properties, such as hydrophobicity and adhesion to human intestinal cells, may be mediated by genes related to cell wall formation and biofilm formation ( luxS , ywqC , desR , and ccpA_2 ), potentially providing a competitive edge for the colonization of the gut environment [ 58 ]. The strong ability of a probiotic strain to attach to the gut enhances its persistence in the gut, prevents pathogens, and allows it to interact with the host to protect epithelial cells or modulate the immune system.…”

Anaerobic flora, Selenomonas ruminis sp. nov., and the bacteriocinogenic Ligilactobacillus salivarius strain MP3 from crossbred-lactating goats

“…The genes associated with increased resistance to clindamycin, erythromycin, and tetracycline were ermC and tet(M). Similarly, L. salivarius CGMCC20700 was reported tetracycline ( tetM, tetL ) and macrolide ( ermC ) resistance-related genes 28 . Tetracycline and erythromycin are commonly used for livestock treatment.…”